Serina Therapeutics CEO Michael West's 2018 pay rises 2% to $1.7M
Serina Therapeutics reports 2018 executive compensation
By ExecPay News
Published: November 24, 2020
Serina Therapeutics reported fiscal year 2018 executive compensation information on November 24, 2020.
In 2018, four executives at Serina Therapeutics received on average a compensation package of $720K, a 16% increase compared to previous year.
Average pay of disclosed executives at Serina Therapeutics
Michael D. West, Chief Executive Officer, received $1.7M in total, which increased by 45% compared to 2017. 62% of West's compensation, or $1M, was in option awards. West also received $39K in bonus, $575K in salary, as well as $10K in other compensation.
Nafees Malik, Chief Operating Officer, received a compensation package of $782K. 93% of the compensation package, or $724K, was in option awards.
Hal Sternberg, Vice President, Research, earned $297K in 2018, a 61% increase compared to previous year.
Alfred D. Kingsley, Chairman, received $150K in 2018, which decreases by 73% compared to 2017.
Related executives
You may also like
Source: SEC filing on November 24, 2020.